Dr Sabine Luik

Sabine Luik, MD, MBA, has been our Chief Medical Officer (CMO) since 2018. She reports directly to the Chief Scientific Officer.

Throughout her tenure with GSK, her leadership has ensured that our regulatory, quality, safety, medical affairs, and value evidence and outcomes teams, as well as development groups in China and Japan, work together to successfully achieve our ambitions for patients.

The organization of the CMO, including Global Regulatory, Safety & Quality, is responsible for benefit-risk decision-making for pipeline and marketed medicines and vaccines, safety and pharmacovigilance, epidemiology, bioethics, medical governance, regulatory policy, quality, and risk management (including data governance).

Across her organization, her teams are driven by delivering what matters better and faster, always in the right way, for patients around the world.

Success in medicine development is directly tied to applying diverse views to problem solving. At GSK, we constantly work to ensure clinical trial participants are representative of the patient populations affected by the diseases we aim to treat. Trials that reflect the true diversity of the population impacted by a disease—such as women’s health issues—will lead to better insights in the development of medicines and how they are prescribed for patients.

Sabine\’s achievements

• 2018 – Present: Chief Medical Officer (CMO) for GSK. Since September 2023, the CMO reports directly to our Chief Scientific Officer.
• 2015 – 2018: Member of the Health Section Governing Board for BIO.
• 2013 – 2018: Membership in senior committees/activity in EFPIA/PhRMA.
• 2012 – Present: Member of the International Council on Harmonisation (ICH) Management Committee on behalf of EFPIA.
• 1998 – 2018: Held senior positions in Medical, Regulatory, and Pharmacovigilance with Boehringer Ingelheim, where she established a global epidemiology team and worked across multiple therapeutic areas.

Education

She received her MD from Johannes Gutenberg University (JGU), Mainz, Germany, and her Executive MBA from JGU in cooperation with the McCombs School of Business, University of Texas, Austin. She is a licensed physician in Germany.

#J-18808-Ljbffr